Skip to main content
A logo

A · Agilent Technologies, Inc. · Investor Relations

Track A — free
Market Cap
$48.43B
Shares
281.93M
Volume · Nov 5 2.7M Avg daily vol (3M) 2.25M

Press releases and events scraped from the company’s investor relations website. Past events open our own call or event page when we host one; otherwise listings link to the original source.

Upcoming events

Date Event Type
2026-11-23 21:30 UTC Q4 2026 Agilent Technologies Inc. Earnings Conference Call Earnings call

Recent news

Date Headline
2026-11-04 Agilent Completes Acquisition of Proscia
2026-11-02 Agilent Launches 5987A MSD with GC Assist for Faster, Smarter GC/MS Workflows
2026-10-29 Agilent to Announce Fourth-Quarter Fiscal Year 2026 Financial Results on Nov. 23
2026-10-27 Agilent and University of Chicago Launch Center of Excellence for Energy Materials Research
2026-10-13 Agilent to Acquire Proscia, Advancing AI-Enabled Digital Pathology and Scientific Intelligence
2026-10-01 Agilent Introduces the NovoStation Sample Preparation System for Automated Flow Cytometry Workflows
2026-09-29 Agilent Introduces Gen5 AI Cell Identification Module for BioTek Automated Cell Imagers
2026-09-21 Agilent Launches TapeStationDx Systems for Clinical NGS Sample Quality Control
2026-09-16 CORRECTING and REPLACING Agilent Announces Cash Dividend of 25.5 Cents per Share
2026-09-16 Agilent Announces Cash Dividend of 25.5 Cents per Share
2026-09-10 Agilent to Participate in J.P. Morgan U.S. All Stars Conference
2026-09-08 Agilent Announces Retirement of Board Chair Koh Boon Hwee, Appointment of Glenn Boehnlein to Board of Directors
2026-09-04 Agilent Expands Digital Pathology Offering with U.S. Launch of the Agilent S540MD Slide Scanner System
2026-09-01 Agilent Introduces the Cary 635 FTIR Spectrometer
2026-08-26 Agilent Reports Third-Quarter Fiscal Year 2026 Financial Results

Delivers strong Q3 results and raises FY26 revenue growth, margin expansion, and non-GAAP EPS(4) guidance on continued operational momentum Third-quarter fiscal year 2026 Revenue of $1.88 billion for the third quarter ended July 31, 2026, representing growth of 8.1% reported and up 7.3% core (1) compared with the third quarter of fiscal year 2025. GAAP operating margin of 23.6%, expanded by 290 basis points year-over-year and 190 basis points sequentially. Non-GAAP operating margin (2) of 28.3% (including an approximately 110 basis point net benefit from tariff refunds), expanded by 320 basis points year-over-year and 190 basis points sequentially. GAAP net income of $362 million; earnings per share (EPS) of $1.28, an increase of 8% from the third quarter of fiscal year 2025. Non-GAAP net income (3) of $459 million (including a $17 million net benefit from tariff refunds); non-GAAP EPS (3) of $1.62 (including a $0.06 net benefit from tariff refunds), an increase of 18% from the third

2026-07-29 Agilent Research Catalyst Award Presented to Eastern Institute of Technology, Ningbo

Eastern Institute of Technology professor recognized for advancing PFAS and emerging contaminant analysis Agilent Technologies Inc. (NYSE: A) today announced that the Eastern Institute of Technology, Ningbo has received an Agilent Research Catalyst (ARC) Award on behalf of Professor Zongwei Cai. The award recognizes Professor Cai's innovative research focused on developing advanced analytical approaches for detecting per- and polyfluoroalkyl substances (PFAS) and other emerging contaminants, a growing area of importance for environmental and public health research. Professor Cai is a globally recognized leader in environmental and bioanalytical chemistry. His research focuses on advancing analytical methods to detect trace environmental contaminants, including PFAS, endocrine-disrupting chemicals, and persistent organic pollutants. By combining high-sensitivity analytical techniques with organoid-based toxicological models, his work aims to improve understanding of how environmental

2026-07-28 Agilent to Announce Third-Quarter Fiscal Year 2026 Financial Results on Aug. 26

Agilent Technologies Inc. (NYSE: A) will release financial results for the third quarter of fiscal year 2026 after the stock market closes on Wednesday, Aug. 26. The company will host a conference call to discuss the results at 1:30 p.m. PDT the same day. To join the listen-only conference call webcast, click the link on the Events section of Agilent’s Investor Relations website. A recording of the call will also be available on the website for 90 days. About Agilent Technologies Agilent Technologies, Inc. (NYSE: A) is a global leader in analytical and clinical laboratory technologies, delivering insights and innovation that help our customers bring great science to life. Agilent’s full range of solutions includes instruments, software, services, and expertise that provide trusted answers to our customers' most challenging questions. The company generated revenue of $6.95 billion in fiscal year 2025 and employs approximately 18,000 people worldwide. Information about Agilent is

2026-07-23 Agilent Receives EU Approval for PD-L1 IHC 22C3 pharmDx in Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Carcinoma
2026-07-14 Agilent Receives FDA Approval for PD-L1 IHC 28-8 pharmDx in Esophageal Squamous Cell Carcinoma (ESCC), Gastric, Gastroesophageal Junction (GEJ), and Esophageal Adenocarcinoma
2026-07-08 Agilent Expands Altura Portfolio with Inert Size Exclusion and PLRP-S Columns for Biotherapeutic Analysis
2026-07-01 Agilent Launches AI-Driven Analysis Module for Agilent xCELLigence RTCA eSight
2026-06-25 Agilent Completes Acquisition of Biocare Medical
2026-06-03 Agilent, OpenAI, BCG Collaborate to Accelerate Customer-Focused, AI-Driven Scientific Innovation
2026-06-02 Agilent Receives FDA Approval for Expanded Use of PD-L1 IHC 22C3 pharmDx on Dako Omnis in Esophageal Squamous Cell Carcinoma, Triple-Negative Breast Cancer, Cervical Cancer, and Gastric or Gastroesophageal Junction Adenocarcinoma
2026-05-28 Agilent Introduces OpenLab Sync to Support Guided, Digital Execution in the Laboratory

Past events

Date Event Type
2026-09-23 J.P. Morgan U.S. All Stars Conference Conference
2026-08-26 Q3 FY2026 Earnings conference call (announced in 8-K) Earnings call
2026-06-03 Jefferies Global Healthcare Conference Conference
2026-05-27 Q2 2026 Agilent Technologies Inc. Earnings Conference Call Earnings call
2026-03-18 2026 Agilent Technologies Annual General Meeting Shareholder meeting
2026-03-03 TD Cowen's 46th Annual Health Care Conference Conference
2026-02-25 Q1 2026 Agilent Technologies Inc. Earnings Conference Call Earnings call
2026-01-13 Agilent to Present at the 44th Annual J.P. Morgan Healthcare Conference Conference
2025-12-04 Agilent to Participate in Citi’s 2025 Global Healthcare Conference Conference
2025-11-24 Q4 2025 Agilent Technologies Inc. Earnings Conference Call Earnings call
2025-09-25 Agilent to Participate in 2025 Bank of America Global Healthcare Conference Conference
2025-09-03 2025 Wells Fargo Healthcare Conference Conference
2025-08-27 Q3 2025 Agilent Technologies Inc. Earnings Conference Call Earnings call
2025-06-04 Jefferies Global Healthcare Conference Conference
2025-05-28 Q2 2025 Agilent Technologies Inc. Earnings Conference Call Earnings call
2025-03-13 2025 Annual General Meeting Shareholder meeting
2025-03-04 TD Cowen 45th Annual Health Care Conference Conference
2025-02-26 Q1 2025 Agilent Technologies Inc. Earnings Conference Call Earnings call
2025-01-14 43rd Annual J.P. Morgan Healthcare Conference Conference
2024-12-17 2024 Agilent Technologies Analyst and Investor Day Presentation
2024-11-25 Q4 2024 Agilent Technologies Inc. Earnings Conference Call Earnings call
2024-08-21 Q3 2024 Agilent Technologies Inc. Earnings Conference Call Earnings call
2024-06-05 Jefferies Global Healthcare Conference Conference
2024-05-29 Q2 2024 Agilent Technologies Inc. Earnings Conference Call Earnings call
2024-03-14 Annual Shareholders Meeting Shareholder meeting

Source: https://www.investor.agilent.com/news-and-events/events/default.aspx

Key facts CIK 1090872 CUSIP 00846U101 13F (30d) 644 filings 600 filers Visit website Investor relations